The U.S. Securities and Exchange Commission (SEC) this week has reopened an investigation into Elon Musk's brain-chip startup ...

The Securities and Exchange Commission is preparing “numerous counts” against Elon Musk, according to a letter from his lawyer that Musk posted to X. It ...

The SEC has not released the letter. Nor would it comment on it or confirm whether it has issued such a demand to Musk.

Under the finalized rule from the Consumer Financial Protection Bureau that was announced Dec. 12, banks will be able to ...

This summary covers key developments in health news, including Mitsubishi Pharma's bidding war, legal actions involving J&J ...

Elon Musk appears to have revealed that the Securities and Exchange Commission issued him a "settlement demand" related to ...

The U.S. Securities and Exchange Commission has given Elon Musk until Monday to respond to an offer to resolve a probe into ...

Elon Musk renewed his longstanding feud with the Securities and Exchange Commission on Thursday by posting a letter that said ...

Neuralink, the brain-technology company co-founded by Elon Musk, has announced the launch of the PRIME Study, a clinical trial for its fully implantable, wireless brain-computer interface (BCI).

Neuralink is therefore launching a new feasibility trial, aimed at extending control of the brain-computer interface using the N1 implant to an experimental assistive robotic arm.

The New York Stock Exchange (NYSE:ICE) and Nasdaq (NASDAQ:NDAQ) are watching closely as the SEC approved the first U.S. stock exchange that would operate during most hours of every weekday.